好色先生

好色先生

Explore the latest content from across our publications

Log In

Forgot Password?
Create New Account

Loading... please wait

Abstract Details

Increased CSF Amyloid beta Protein 1-38 (A[beta]38)/A[beta]42 Ratio in Alzheimer Disease
Aging and Dementia
(-)
139
Authors/Disclosures
Tijil Agarwal, MD Dr. Agarwal has nothing to disclose.
Alejandro Santillan, MD (New York Presbyterian Hospital/Weill Cornell Medical Center) No disclosure on file
Andrew Slusher, MD (St Thomas Midtown Hospital) No disclosure on file
Venkat Raghav Aachi, MD Dr. Aachi has nothing to disclose.
Lauren Fanty, MD (Fixel Institute) Dr. Fanty has nothing to disclose.
Reza Behrouz, DO, PhD, FAAN (University of Texas Health Science Center San Antonio) No disclosure on file
Christopher H. Topel, MD (UT Health Sciences San Antonio) No disclosure on file
No disclosure on file
Vivek Misra, MD (Houston Methodist Hospital) Dr. Misra has nothing to disclose.
Lee Birnbaum, MD Dr. Birnbaum has nothing to disclose.
Santiago Palacio, MD (UTHSCSA) No disclosure on file
Benjamin R. Brooks, MD, FAAN (Clinical Trials Planning LLC) Dr. Brooks has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Mitsubishi Tanabe Pharma America. Dr. Brooks has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Medicinova. Dr. Brooks has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Brooks has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for AB Science. Dr. Brooks has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Ionis. Dr. Brooks has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Mitsubishi Tanabe Pharma America. The institution of Dr. Brooks has received research support from Mitsubishi TanabePharma America. Dr. Brooks has received personal compensation in the range of $0-$499 for serving as a Member Annual Surveillance Committee CDC National ALS Registry with Center for Disease Control Agency Toxic Substances Disease Registry. Dr. Brooks has a non-compensated relationship as a Member ALS Quality Measures Subcommittee with 好色先生 that is relevant to AAN interests or activities.